Skip to Main Content

Paper Details

International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer.
Mol Cancer Ther
10
2021
Cancer, Children, cancer, cell, children, high, malignant solid tumors, mouse, patient, patients, pediatric, pediatric cancer, pediatric solid malignancies, pediatric solid tumors, tumor
Author NameAffiliation
Gilles VassalInstitute Gustave Roussy, Universite Paris Saclay
Peter J HoughtonGreehey Children's Cancer Research Institute
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) and University Hospital
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) and University Hospital
Malcolm A SmithNational Cancer Institute
Malcolm A SmithNational Cancer Institute
Xiao-Nan LiAnn and Robert H. Lurie Children's Hospital of Chicago
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) and University Hospital
Olaf WittHopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) and University Hospital
Jan J Molenaar
  • 1 - 10

Datasets

Release 1.2